Particle.news

Download on the App Store

POT1-L259S Blocks Telomerase, Linking Shelterin Defect to Pulmonary Fibrosis

A CNIO mouse study indicates patients with this mutation will require therapies other than telomerase activation.

Overview

  • Researchers show the POT1-L259S mutation prevents telomerase from repairing telomeres, producing short, dysfunctional chromosome ends.
  • Knock-in mice carrying the human-equivalent mutation display a telomerase-deficiency-like phenotype with progressive telomere shortening across generations.
  • The work marks the first association of a shelterin protein mutation with a degenerative lung disease rather than cancer predisposition.
  • Findings suggest telomerase-based approaches under development would not correct fibrosis driven by this specific defect, underscoring personalized treatment needs.
  • The study, published in Genes & Development and led by CNIO’s Telomeres and Telomerase Group, was funded by the ERC’s SHELTERINS project.